Search

Your search keyword '"Dagna, Lorenzo"' showing total 1,582 results

Search Constraints

Start Over You searched for: Author "Dagna, Lorenzo" Remove constraint Author: "Dagna, Lorenzo"
1,582 results on '"Dagna, Lorenzo"'

Search Results

3. Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial

4. Clinical Aspects of Rheumatoid Arthritis

5. Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

6. High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation

7. Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies

9. Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

10. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis

11. Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study

15. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

16. Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study

18. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

19. Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study

20. Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

22. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

23. Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission

26. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

27. Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report

29. Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies

30. Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial

31. The administration of methotrexate in patients with Still's disease, “real-life” findings from AIDA Network Still Disease Registry

34. DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients

35. Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study

36. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment

37. Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases

38. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

40. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis

41. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature

43. Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study

44. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology

46. One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical Ventilation

48. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life

49. Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients

50. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia

Catalog

Books, media, physical & digital resources